Allison S. Cleary
No Rating Available
(Learn About Our Rating System)

Allison S. Cleary, MD, PhD

Languages spoken: English

  • Specialties

    • Pathology

    Board Certification

    American Board of Pathology (Anatomic & Clinical)

  • Board Certification and Academic Information

    Academic Departments Pathology -Primary
    Board Certification
    American Board of Pathology (Anatomic & Clinical)

    Education history

    Residency Anatomic Pathology - Brigham and Women's Hospital Chief Resident
    Breast Pathology - Brigham and Women’s Hospital Fellow
    Residency Anatomic and Clinical Pathology - Brigham and Women’s Hospital Resident
    Cell and Molecular Biology - Pennsylvania State University College of Medicine Ph.D.
    Professional Medical Medicine - Pennsylvania State University College of Medicine M.D.
    Molecular, Cellular, and Developmental Biology - University of Colorado B.A.
    Undergraduate General Sciences - Arapahoe Community College A.S.

    Selected Publications

    Journal Article

    1. Balatico M, Ruano AL, Cleary AS, Lomo L, Gulbahce HE (2023). Male Invasive Lobular Breast Cancer: Clinicopathologic Features Including Recurrence Score Results From a Population-Based Database. Arch Pathol Lab Med, 148(3), 263-264. (Read full article)
    2. McMurtry V, Cleary AS, Ruano AL, Lomo L, Gulbahce HE (2023). Metaplastic Breast Carcinoma: Clinicopathologic Features and Recurrence Score Results From a Population-based Database. Am J Clin Oncol, 46(12), 559-566. (Read full article)
    3. Wilcock D, Sirohi D, Albertson D, Cleary AS, Coleman JF, Jedrzkiewicz J, Mahlow J, Ruano AL, Gulbahce HE (2023). Clinicopathologic Features of Breast Carcinoma With 2018 American Society of Clinical Oncology/College of American Pathologists Fluorescence In Situ Hybridization Group 3 (Human Epidermal Growth Factor Receptor 2 Chromosome 17 Centromere Ratio <2.0 and Average Human Epidermal Growth Factor Receptor 2 Copy Number ≥6.0) Breast Cancers. Arch Pathol Lab Med. (Read full article)
    4. Wilcock DM, Moore KH, Rowe L, Mahlow J, Jedrzkiewicz J, Cleary AS, Lomo L, Ruano AL, Gering M, Bradshaw D, Maughan M, Tran P, Burlingame J, Davis R, Affolter K, Albertson DJ, Adelhardt P, Kim JT, Coleman JF, Deftereos G, Gulbahce EH, Sirohi D (2023). Quantitative Imaging Analysis Fluorescence In Situ Hybridization Validation for Clinical HER2 Testing in Breast Cancer. Arch Pathol Lab Med. (Read full article)
    5. Cleary AS, OHara C, Helm KF (2016). Granulomatous Ulcer Arising in a Child. Pediatr Dermatol, 33(5), 551-2. (Read full article)
    6. Truica CI, Cleary AS (2015). Immunotherapy in Breast Cancer- Paving New Roads? Curr Mol Pharmacol, 9(3), 208-216. (Read full article)
    7. Cleary AS (2016). Teamwork: The tumor cell edition. Science, 350(6265), 1174-5. (Read full article)
    8. Cleary AS, Leonard TL, Gestl SA, Gunther EJ (2013). Tumour cell heterogeneity maintained by cooperating subclones in Wnt-driven mammary cancers. Nature, 508(7494), 113-7. (Read full article)
    9. Allen DL, Cleary AS, Hanson AM, Lindsay SF, Reed JM (2010). CCAAT/enhancer binding protein-delta expression is increased in fast skeletal muscle by food deprivation and regulates myostatin transcription in vitro. Am J Physiol Regul Integr Comp Physiol, 299(6), R1592-601. (Read full article)
    10. Allen DL, Cleary AS, Lindsay SF, Loh AS, Reed JM (2010). Myostatin expression is increased by food deprivation in a muscle-specific manner and contributes to muscle atrophy during prolonged food deprivation in mice. J Appl Physiol (1985), 109(3), 692-701. (Read full article)
    11. Allen DL, Greybeck BJ, Hanson AM, Cleary AS, Lindsay SF (2010). Skeletal muscle expression of bone morphogenetic protein-1 and tolloid-like-1 extracellular proteases in different fiber types and in response to unloading, food deprivation and differentiation. J Physiol Sci, 60(5), 343-52. (Read full article)
    12. Allen DL, Uyenishi JJ, Cleary AS, Mehan RS, Lindsay SF, Reed JM (2009). Calcineurin activates interleukin-6 transcription in mouse skeletal muscle in vivo and in C2C12 myotubes in vitro. Am J Physiol Regul Integr Comp Physiol, 298(1), R198-210. (Read full article)
    13. Allen DL, Cleary AS, Speaker KJ, Lindsay SF, Uyenishi J, Reed JM, Madden MC, Mehan RS (2008). Myostatin, activin receptor IIb, and follistatin-like-3 gene expression are altered in adipose tissue and skeletal muscle of obese mice. Am J Physiol Endocrinol Metab, 294(5), E918-27. (Read full article)
    14. Konhilas JP, Widegren U, Allen DL, Paul AC, Cleary A, Leinwand LA (2005). Loaded wheel running and muscle adaptation in the mouse. Am J Physiol Heart Circ Physiol, 289(1), H455-65. (Read full article)

    Review

    1. Cleary AS, Lester SC (2022). The Critical Role of Breast Specimen Gross Evaluation for Optimal Personalized Cancer Care. [Review]. Surg Pathol Clin, 15(1), 121-132. (Read full article)

    Letter

    1. Ng J, Cleary A, Tsukada H, Goldberg H (2017). A case of recipient-derived pulmonary Kaposi sarcoma after bilateral lung transplantation. [Letter to the editor]. J Heart Lung Transplant, 37(6), 798-799. (Read full article)